Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
- PMID: 29389364
- PMCID: PMC5780297
- DOI: 10.1016/j.jacc.2017.11.037
Prevalence of Cardiac Amyloidosis in Patients Referred for Transcatheter Aortic Valve Replacement
Figures
References
-
- Gillmore J.D., Maurer M.S., Falk R.H. Nonbiopsy diagnosis of cardiac transthyretin amyloidosis. Circulation. 2016;133:2404–2412. - PubMed
-
- Tanskanen M., Peuralinna T., Polvikoski T. Senile systemic amyloidosis affects 25% of the very aged and associates with genetic variation in alpha2-macroglobulin and tau: a population-based autopsy study. Ann Med. 2008;40:232–239. - PubMed
-
- Treibel T.A., Fontana M., Gilbertson J.A. Occult transthyretin cardiac amyloid in severe calcific aortic stenosis: prevalence and prognosis in patients undergoing surgical aortic valve replacement. Circ Cardiovasc Imaging. 2016;9 - PubMed
-
- González-López E., Gallego-Delgado M., Guzzo-Merello G. Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction. Eur Heart J. 2015;36:2585–2594. - PubMed
